Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01851239

Enrollment

1000

Registered

2013-05-10

Start date

2013-02-28

Completion date

2014-04-30

Last updated

2014-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thromboembolism

Keywords

Venous Thromboembolism Prophylaxis, ICU

Brief summary

Venous thromboembolism(VTE) is the third most common cardiovascular complication among hospitalized patients, and can even cause death. VTE often occurs in intensive care patients and there had been many efforts to prevent such complication. The American College of Chest Physicians (ACCP) had published evidence-based clinical practice guideline for VTE prophylaxis. This study focuses on how VTE prophylaxis is being performed in both medical and surgical ICUs in a single University hospital, and sees the differences in such prophylactic patterns.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

* ICU admitted patients

Exclusion criteria

* patients under 20 years old

Design outcomes

Primary

Measure	Time frame	Description
number of patients prescribed with any measures of VTE prophylaxis in ICU	at the time of ICU admission an expected average of 5 months (When VTE prophylaxis for each patient is being ordered)	The object of this study is to see the percentage of ICU admitted patients prescribed with VTE prophylaxis, and analyze the adequacy of such prophylactic measure according to the international guideline. Moreover, difference between the VTE prophylaxis pattern of medical and surgical ICUs will also be seek for further analysis.

Countries

South Korea

Outcome results